Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Brunetti

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Nature Cell Biology|April 6, 2023
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cellsRaghav Ramabadran, Jarey H Wang, Jaime M Reyes, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid LeukemiaGandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
Cell Stem Cell|July 17, 2020
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic ErosionAyala Tovy, Jaime M Reyes, Michael C Gundry, et al.
Cancer Discovery|August 25, 2021
Systematic Profiling of <i>DNMT3A</i> Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase AdaptorYung-Hsin Huang, Chun-Wei Chen, Venkatasubramaniam Sundaramurthy, et al.
Haematologica|June 7, 2021
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndromeAyala Tovy, Carina Rosas, Amos S Gaikwad, et al.
Cell|November 5, 2025
Disparate leukemia mutations converge on nuclear phase-separated condensatesGandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
Leukemia|March 25, 2020
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expressionKristen Fousek, Junji Watanabe, Sujith K Joseph, et al.
Blood|August 3, 2021
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AMLMaria Paola Martelli, Roberta Rossi, Alessandra Venanzi, et al.
Blood|December 12, 2022
Overlapping features of therapy-related and de novo NPM1-mutated AMLJad Othman, Manja Meggendorfer, Enrico Tiacci, et al.
American Journal of Hematology|January 20, 2025
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating AgentsGiovanni Marconi, Elisabetta Petracci, Giuseppe Lanzarone, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Nature Cell Biology|April 6, 2023
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cellsRaghav Ramabadran, Jarey H Wang, Jaime M Reyes, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid LeukemiaGandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
Cell Stem Cell|July 17, 2020
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic ErosionAyala Tovy, Jaime M Reyes, Michael C Gundry, et al.
Cancer Discovery|August 25, 2021
Systematic Profiling of <i>DNMT3A</i> Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase AdaptorYung-Hsin Huang, Chun-Wei Chen, Venkatasubramaniam Sundaramurthy, et al.
Haematologica|June 7, 2021
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndromeAyala Tovy, Carina Rosas, Amos S Gaikwad, et al.
Cell|November 5, 2025
Disparate leukemia mutations converge on nuclear phase-separated condensatesGandhar K Datar, Elmira Khabusheva, Archish Anand, et al.
Leukemia|March 25, 2020
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expressionKristen Fousek, Junji Watanabe, Sujith K Joseph, et al.
Blood|August 3, 2021
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AMLMaria Paola Martelli, Roberta Rossi, Alessandra Venanzi, et al.
Blood|December 12, 2022
Overlapping features of therapy-related and de novo NPM1-mutated AMLJad Othman, Manja Meggendorfer, Enrico Tiacci, et al.
American Journal of Hematology|January 20, 2025
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating AgentsGiovanni Marconi, Elisabetta Petracci, Giuseppe Lanzarone, et al.
Pageof 6